Valued at a market cap of $600 million, Aduro is a small-cap Canadian stock that offers massive upside potential in 2025.
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...
Johnson & Johnson recently reported Phase 3 data showing that its TECVAYLI plus DARZALEX FASPRO combination cut the risk of ...
This article is the second installment in our three-part series, Artificial Intelligence as Intellectual Property or “AI as IP™”, which explores ...
FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...
Product liability and real estate practices are well represented, as the Am Law 50 firm returns to electing a typical number of new partners.
5dOpinion
InnoScience Makes Progress In Patent Dispute, But Growing Competition Remains Bigger Threat
Morgan Stanley, in an October note, projected that InnoScience's revenue would outpace overall GaN market growth, expanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback